Deguchi A, Kawamura K, Deguchi K, Tamaki S, Tanigawa M, Iwasaki E, Wada H, Murashima S, Nishikawa M, Shirakawa S
Oyamada Memorial Spa Hospital, Yokkaichi.
Rinsho Byori. 1991 May;39(5):517-22.
The fibrin lysis activity in the presence of enough quantity of C1 inactivator (C1.INA) is called C1.INA resistant fibrinolytic activity (C1.IRFA). C1.INA inhibits the activation of intrinsic fibrinolysis, therefore C1.IRFA is considered to reflect the extrinsic fibrinolytic activity mainly. We studied the effect of C1.INA using fibrin plate assay on fibrin lysis activity (FLA) and C1.IRFA in normal individuals and pregnant women, and studied the fluctuation of FLA and C1.IRFA during venous occlusion test (VO) or 1-deamino-8-D-arginine vasopressin (DDAVP) administration. After VO or DDAVP administration, the euglobulin lysis time (ELT) was reduced, FLA increased and C1.IRFA also increased. The increase in C1.IRFA accounted for most of the increase in FLA. Therefore, the increased fibrinolytic activity during VO or DDAVP administration is due to extrinsic fibrinolytic activity. In the pregnant women, the fibrinolytic activity was decreased during pregnancy and the low fibrinolytic activity is suggested to be involved in the low extrinsic fibrinolytic activity. The measurement of C1.IRFA is considered to be useful.
在存在足量C1灭活剂(C1.INA)的情况下的纤维蛋白溶解活性称为C1.INA抗性纤维蛋白溶解活性(C1.IRFA)。C1.INA抑制内源性纤维蛋白溶解的激活,因此C1.IRFA主要被认为反映外源性纤维蛋白溶解活性。我们使用纤维蛋白平板试验研究了C1.INA对正常个体和孕妇的纤维蛋白溶解活性(FLA)和C1.IRFA的影响,并研究了在静脉闭塞试验(VO)或给予1-去氨基-8-D-精氨酸加压素(DDAVP)期间FLA和C1.IRFA的波动情况。在VO或给予DDAVP后,优球蛋白溶解时间(ELT)缩短,FLA增加,C1.IRFA也增加。C1.IRFA的增加占FLA增加的大部分。因此,在VO或给予DDAVP期间纤维蛋白溶解活性的增加是由于外源性纤维蛋白溶解活性。在孕妇中,孕期纤维蛋白溶解活性降低,提示低纤维蛋白溶解活性与低外源性纤维蛋白溶解活性有关。C1.IRFA的测定被认为是有用的。